Related Experiment Video
Updated: Feb 8, 2026

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
Published on: May 13, 2022
DEFINING INNOVATION WITH RESPECT TO NEW MEDICINES: A SYSTEMATIC REVIEW FROM A PAYER PERSPECTIVE
Oriol de Solà-Morales1, David Cunningham2, Mathias Flume3
1Health Innovation Technology Transfer (HITT)osola@hittinnova.com.
Objectives:
The aim of this study was to investigate how innovation is defined with respect to new medicines.
Methods:
MEDLINE, Embase, and EconLit databases were searched for articles published between January 1, 2010 and May 25, 2016 that described a relevant definition of innovation. Identified definitions were analyzed by mapping the concepts described onto a set of ten dimensions of innovation.
Results:
In total, thirty-six articles were included, and described a total of twenty-five different definitions of innovation. The most commonly occurring dimension was therapeutic benefit, with novelty and the availability of existing treatments the second and third most common dimensions. Overall, there was little agreement in the published literature on what characteristics of new medicines constitute rewardable innovation.
Conclusions:
Alignment across countries and among regulators, health technology assessment bodies and payers would help manufacturers define research policies that can drive innovation, but may be challenging, as judgements about what aspects of innovation should be rewarded vary among stakeholders, and depend on political and societal factors.
Related Concept Videos
Area Between Curves: Integrating With Respect to y
Area Between Curves: Integrating With Respect to x
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Random and Systematic Errors

